Items where authors include "Cortes, J"

Article

Boschetty, F, Ferguson, D, Cortes, J et al. (5 more authors) (2022) Insights into Magma Storage Beneath a Frequently Erupting Arc Volcano (Villarrica, Chile) from Unsupervised Machine Learning Analysis of Mineral Compositions. Geochemistry, Geophysics, Geosystems. ISSN 1525-2027

O’Shaughnessy, J, Cortes, J, Twelves, C et al. (5 more authors) (2020) Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis. Scientific Reports, 10 (1). 11203. ISSN 2045-2322

Cortes, J and Twelves, C (2020) Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: A post hoc pooled analysis. Breast Journal, 26 (7). pp. 1347-1351. ISSN 1075-122X

Schmid, P, Abraham, J, Chan, S et al. (26 more authors) (2020) Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial. Journal of Clinical Oncology, 38 (5). pp. 423-433. ISSN 0732-183X

Rugo, HS, Cortes, J, Awada, A et al. (12 more authors) (2018) Change in Topoisomerase 1–Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol. Clinical Cancer Research, 24 (14). pp. 3348-3357. ISSN 1078-0432

Silva-Rodriguez, J, Cortes, J, Rodriguez-Osorio, X et al. (4 more authors) (2016) Iterative Structural and Functional Synergistic Resolution Recovery (iSFS-RR) Applied to PET-MR Images in Epilepsy. IEEE Transactions on Nuclear Science, 63 (5). pp. 2434-2442. ISSN 0018-9499

Twelves, C, Awada, A, Cortes, J et al. (6 more authors) (2016) Subgroup analyses from a phase 3, open-label, randomized study of eribulin mesylate versus capecitabine in pretreated patients with advanced or metastatic breast cancer. Breast Cancer: Basic and Clinical Research, 10. pp. 77-84.

Cortes, J, Hudgens, S, Twelves, C et al. (7 more authors) (2015) Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial. Breast cancer research and treatment, 154 (3). 509 - 520. ISSN 0167-6806

Silva-Rodríguez, J, Tsoumpas, C orcid.org/0000-0002-4971-2477, Aguiar, P et al. (2 more authors) (2015) Resolution improvement of brain PET images using prior information from MRI: clinical application on refractory epilepsy. EJNMMI Physics, 2 (Suppl 1). A72. ISSN 2197-7364

Kaufman, PA, Awada, A, Twelves, C et al. (7 more authors) (2015) Phase III Open-Label Randomized Study of Eribulin Mesylate Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane. Journal of Clinical Oncology, 33 (6). pp. 594-601. ISSN 0732-183X

Kaufmann, PA, Cortes, J, Awada, A et al. (8 more authors) (2013) A Phase Ill, open-label, randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes: Subgroup analyses. Onkologie: international journal for cancer research and treatment, 36 (Suppl 7). p. 97. ISSN 0378-584X

Proceedings Paper

Tripathy, D, Sara, T, Seidman, AD et al. (9 more authors) (2018) ATTAIN: Phase 3 study of etirinotecan pegol (EP) vs treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC). In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas, U.S.A.. American Association for Cancer Research .

Tripathy, D, Tolaney, S, Seidman, AD et al. (5 more authors) (2017) Phase 3 study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer who have stable brain metastases previously treated with an anthracycline, a taxane, and capecitabine. In: Cancer Research. 2016 San Antonio Breast Cancer Symposium, 06 Dec 2016 - 10 Dec 2010, San Antonio, Texas, U.S.A.. American Association for Cancer Research .

O'Shaughnessy, J, Rugo, H, Awada, A et al. (16 more authors) (2016) Etirinotecan pegol (EP) significantly improves overall survival in patients with advanced breast cancer (aBC) and a history of brain metastases (BM). In: European Journal of Cancer. 10th European Breast Cancer Conference (EBCC-10), 09-11 Mar 2016, Amsterdam, Netherlands. Elsevier , S111-S112.

Melancon, M, Hunter, P, Hourcade, S et al. (7 more authors) (2014) The effect of four commercially available steel decontamination processes on the performance of external coatings. In: NACE - International Corrosion Conference Series. International Corrosion Conference Series 2014, 09-13 Mar 2014, San Antonio, Texas, USA. National Assoc. of Corrosion Engineers International .